バイオプロセスコンテナ市場

出版：MarketsandMarkets

Bioprocess Containers Market by Type(2D and 3D Bags, Accessories), Application(Process development, Upstream and Downstream Process), End User(Pharma & Biopharma Companies, CMOs & CROs, Academic & Research Institute), & Region – Global Forecast to 2026

–

–

バイオプロセスコンテナ市場 タイプ（2D、3Dバッグ、アクセサリ）、用途（プロセス開発、上流、下流プロセス）、エンドユーザー（製薬およびバイオ医薬品企業、CMO、CRO、学術、研究所）、地域別

The global bioprocess containers (BPCs) market is projected to grow from USD 2.9 billion in 2021 to USD 9.6 billion by 2026, at a CAGR of 26.3% during the forecast period. Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D. Emerging countries and the patent expiry of biologics are expected to offer growth opportunities for players operating in the bioprocess containers market during the forecast period.
“By end user segment, the CROs & CMOssegmentaccounted for the fastest-growing segment of thebioprocess containers market”
On the basis of end user, the bioprocess containers market is segmented into pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes. The CROs & CMOs segment is expected to be the fastest-growing segmentduring the forecast period.Growth in the number of biotechnology companies, a growing number of research projects in the pharmaceutical industry, and an increasing preference for outsourcing research and manufacturing activities are the key factors driving the growth of this segment.
“By application, the upstream processes segment accounted for the largest share of thebioprocess containers market”
On the basis of application, the bioprocess containers market is segmented into upstream processes, downstream processes, and process development. In 2020, the upstream processes segment accounted for the largest share of the bioprocess containers market. Upstream processes make the highest use of bioprocess containers, especially during fermentation and culture media processing; due to this, this segment holds the largest market share.
“Asia Pacific: The fastest-growing region in the bioprocess containersmarket.”
The APAC market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceuticals industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies and key players in the region, and the growing number of CROs & CMOs in several APAC countries are contributing to the growth of this market.
“North America: the largest share of the bioprocess containers market”
North America accounted for the largest share of the bioprocess containers market. The large share of North America can be attributed to the presence of an established biopharmaceuticals industry and major players in the region.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

•By Respondent– Supply Side- 67%, Demand Side-33%
•By Designation— CXOsand Directors- 18%, Executives – 25%, Mangers – 57%
•By Region— North America – 50%, Europe – 20%, APAC – 20%, RoW- 10%

The bioprocess containers market is dominated by a few globally established players such as Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck Millipore (Germany), Parker-Hannifin Corporation (US), Lonza AG (Switzerland), Michelin Group (France), Antylia Scientific (US), ABEC, Inc. (US), Meissner Filtration Products, Inc. (US), Avantor, Inc. (US), Corning Incorporated (US), and Entegris, Inc. (US), FlexBiosys Inc. (US), Cellexus (UK), Keofitt A/S (Denmark), FUJIMORI KOGYO CO., LTD. (Japan), CESCO Bioengineering Co., Ltd. (Taiwan), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech BV (Netherlands), Foxx Life Sciences (US), and Shanghai Lepure Biotechnology Co., Ltd. (China).
Research Coverage:

The report segments the bioprocess containers market based on region (Asia Pacific, Europe, North America, and Rest of the World), type (2D bioprocess containers, 3D bioprocess containers, and other containers and accessories), application(upstream processes, downstream processes, and process development), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the bioprocess containersmarket.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the bioprocess containersmarket and provides them information on key market drivers, restraints, challenges, and opportunities.

目次

1INTRODUCTION32
1.1OBJECTIVES OF THE STUDY32
1.2MARKET DEFINITION33
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY33
1.3MARKET SCOPE33
1.3.1MARKETS COVERED33
FIGURE 1BIOPROCESS CONTAINERS MARKET SEGMENTATION33
1.3.2YEARS CONSIDERED FOR THE STUDY34
1.4CURRENCY34
1.5LIMITATIONS34
1.6STAKEHOLDERS35
1.7SUMMARY OF CHANGES35
2RESEARCH METHODOLOGY36
2.1RESEARCH DESIGN36
FIGURE 2RESEARCH DESIGN36
2.1.1SECONDARY DATA37
2.1.1.1Secondary sources: Bioprocess containers market38
2.1.2PRIMARY DATA38
FIGURE 3BREAKDOWN OF PRIMARIES: BIOPROCESS CONTAINERS MARKET39
2.1.2.1Key data from primary sources39
2.2MARKET SIZE ESTIMATION40
FIGURE 4RESEARCH METHODOLOGY: HYPOTHESIS BUILDING40
2.2.1REVENUE MAPPING-BASED MARKET ESTIMATION41
FIGURE 5MARKET SIZE ESTIMATION: BIOPROCESS CONTAINERS MARKET41
2.2.2PRIMARY RESEARCH VALIDATION41
FIGURE 6BIOPROCESS CONTAINERS MARKET: CAGR PROJECTIONS42
2.3MARKET BREAKDOWN AND DATA TRIANGULATION43
FIGURE 7DATA TRIANGULATION METHODOLOGY43
2.4ASSUMPTIONS FOR THE STUDY44
3EXECUTIVE SUMMARY45
FIGURE 8BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)45
FIGURE 9BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)46
FIGURE 10BIOPROCESS CONTAINERS MARKET SHARE, BY END USER, 202047
FIGURE 11GEOGRAPHICAL SNAPSHOT OF THE BIOPROCESS CONTAINERS MARKET48
 
4PREMIUM INSIGHTS49
4.1BIOPROCESS CONTAINERS MARKET OVERVIEW49
FIGURE 12GROWING BIOLOGICS MARKET TO DRIVE MARKET GROWTH49
4.2ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE & COUNTRY (2020)50
FIGURE 132D BIOPROCESS CONTAINERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 202050
4.3BIOPROCESS CONTAINERS MARKET, BY END USER51
FIGURE 14CMOS & CROS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD51
5MARKET OVERVIEW52
5.1INTRODUCTION52
5.2MARKET DYNAMICS52
FIGURE 15BIOPROCESS CONTAINERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES52
5.2.1DRIVERS53
5.2.1.1Growing biologics market53
FIGURE 16GLOBAL BIOLOGICS MARKET, 2014─2023 (USD BILLION)53
5.2.1.2Affordability and sustainability of single-use bioprocess technologies54
FIGURE 17ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING, 201955
5.2.1.3Rising biopharmaceutical R&D55
FIGURE 18GLOBAL R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010−2025 (USD BILLION)56
5.2.2RESTRAINTS56
5.2.2.1Issues related to leachables and extractables56
TABLE 1TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS57
5.2.3OPPORTUNITIES57
5.2.3.1Emerging countries57
5.2.3.2Patent expiry of biologics58
TABLE 2US: BIOLOGICS GOING OFF-PATENT DURING 2018–202558
5.2.4CHALLENGES58
5.2.4.1Waste disposal58
TABLE 3COMPARISON OF DISPOSAL OPTIONS FOR SINGLE-USE ASSEMBLY PRODUCTS59
5.3IMPACT OF COVID-19 ON THE BIOPROCESS CONTAINERS MARKET59
FIGURE 19COVID-19 IMPACT ON THE BIOPROCESS CONTAINERS MARKET, 2019─2021, (USD MILLION)59
 
6BIOPROCESS CONTAINERS MARKET, BY TYPE61
6.1INTRODUCTION62
TABLE 4BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017–2020 (USD MILLION)62
TABLE 5BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021–2026 (USD MILLION)63
6.22D BIOPROCESS CONTAINERS63
6.2.1WIDE USE OF 2D BAGS IN BIOPRODUCTION APPLICATIONS TO DRIVE MARKET GROWTH63
TABLE 6EXAMPLES OF 2D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET64
TABLE 72D BIOPROCESS CONTAINERS MARKET, BY REGION,
2017–2020 (USD MILLION)64
TABLE 82D BIOPROCESS CONTAINERS MARKET, BY REGION,
2021–2026 (USD MILLION)64
TABLE 9NORTH AMERICA: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)65
TABLE 10NORTH AMERICA: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)65
TABLE 11EUROPE: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION)65
TABLE 12EUROPE: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)66
TABLE 13ASIA PACIFIC: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)66
TABLE 14ASIA PACIFIC: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)67
6.33D BIOPROCESS CONTAINERS67
6.3.1SIGNIFICANT REDUCTIONS IN LABOR COSTS AND FASTER BATCH TURNAROUND ACHIEVED USING THESE CONTAINERS TO PROPEL MARKET GROWTH67
TABLE 15EXAMPLES OF 3D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET67
TABLE 163D BIOPROCESS CONTAINERS MARKET, BY REGION,
2017–2020 (USD MILLION)68
TABLE 173D BIOPROCESS CONTAINERS MARKET, BY REGION,
2021–2026 (USD MILLION)68
TABLE 18NORTH AMERICA: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)68
TABLE 19NORTH AMERICA: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)69
TABLE 20EUROPE: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION)69
TABLE 21EUROPE: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)70
TABLE 22ASIA PACIFIC: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION)70
TABLE 23ASIA PACIFIC: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)71
6.4OTHER CONTAINERS & ACCESSORIES71
TABLE 24OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY REGION, 2017–2020 (USD MILLION)71
TABLE 25OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY REGION, 2021–2026 (USD MILLION)72
TABLE 26NORTH AMERICA: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)72
TABLE 27NORTH AMERICA: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)72
TABLE 28EUROPE: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET,
BY COUNTRY, 2017–2020 (USD MILLION)73
TABLE 29EUROPE: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET,
BY COUNTRY, 2021–2026 (USD MILLION)73
TABLE 30ASIA PACIFIC: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)74
TABLE 31ASIA PACIFIC: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)74
7BIOPROCESS CONTAINERS MARKET, BY APPLICATION75
7.1INTRODUCTION76
TABLE 32BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)76
TABLE 33BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)77
7.2UPSTREAM PROCESSES77
7.2.1FREQUENT USE OF BIOPROCESS CONTAINERS DURING FERMENTATION AND CULTURE MEDIA PROCESSING IS A MAJOR FACTOR DRIVING THE MARKET77
TABLE 34BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES,
BY REGION, 2017–2020 (USD MILLION)78
TABLE 35BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES,
BY REGION, 2021–2026 (USD MILLION)78
TABLE 36NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017–2020 (USD MILLION)78
TABLE 37NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021–2026 (USD MILLION)79
TABLE 38EUROPE: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017–2020 (USD MILLION)79
TABLE 39EUROPE: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021–2026 (USD MILLION)80
TABLE 40ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017–2020 (USD MILLION)80
TABLE 41ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021–2026 (USD MILLION)81
7.3DOWNSTREAM PROCESSES81
7.3.1WIDE USAGE OF BPC ASSEMBLY FOR PURIFICATION APPLICATIONS TO DRIVE MARKET GROWTH81
TABLE 42BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES,
BY REGION, 2017–2020 (USD MILLION)82
TABLE 43BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES,
BY REGION, 2021–2026 (USD MILLION)82
TABLE 44NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017–2020 (USD MILLION)82
TABLE 45NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021–2026 (USD MILLION)83
TABLE 46EUROPE: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017–2020 (USD MILLION)83
TABLE 47EUROPE: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021–2026 (USD MILLION)84
TABLE 48ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017–2020 (USD MILLION)84
TABLE 49ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021–2026 (USD MILLION)85
7.4PROCESS DEVELOPMENT85
7.4.1REDUCED RISK OF CROSS-CONTAMINATION AND REDUCED OPERATIONAL COSTS MAKE BPCS THE MOST PREFERRED SOLUTION FOR PROCESS DEVELOPMENT85
TABLE 50BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT,
BY REGION, 2017–2020 (USD MILLION)86
TABLE 51BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT,
BY REGION, 2021–2026 (USD MILLION)86
TABLE 52NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)86
TABLE 53NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)87
TABLE 54EUROPE: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)87
TABLE 55EUROPE: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)88
TABLE 56ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)88
TABLE 57ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)89
8BIOPROCESS CONTAINERS MARKET, BY END USER90
8.1INTRODUCTION91
TABLE 58BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)91
TABLE 59BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)91
8.2PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES92
8.2.1BPCS HAVE FOUND WIDE USE IN BIOPHARMACEUTICAL MANUFACTURING DUE TO THEIR COST-EFFECTIVENESS92
TABLE 60BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION)92
TABLE 61BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION)93
TABLE 62NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)93
TABLE 63NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)93
TABLE 64EUROPE: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2017–2020 (USD MILLION)94
TABLE 65EUROPE: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2021–2026 (USD MILLION)94
TABLE 66ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2017–2020 (USD MILLION)95
TABLE 67APAC: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2021–2026 (USD MILLION)95
8.3CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS96
8.3.1INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT MARKET GROWTH96
TABLE 68BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY REGION,
2017–2020 (USD MILLION)96
TABLE 69BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY REGION,
2021–2026 (USD MILLION)97
TABLE 70NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)97
TABLE 71NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)97
TABLE 72EUROPE: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS,
BY COUNTRY, 2017–2020 (USD MILLION)98
TABLE 73EUROPE: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS,
BY COUNTRY, 2021–2026 (USD MILLION)98
TABLE 74ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS,
BY COUNTRY, 2017–2020 (USD MILLION)99
TABLE 75ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS,
BY COUNTRY, 2021–2026 (USD MILLION)99
8.4ACADEMIC & RESEARCH INSTITUTES100
8.4.1GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET GROWTH100
TABLE 76BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION)100
TABLE 77BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION)100
TABLE 78NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)101
TABLE 79NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)101
TABLE 80EUROPE: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)101
TABLE 81EUROPE: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)102
TABLE 82ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)102
TABLE 83ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)103
9BIOPROCESS CONTAINERS MARKET, BY REGION104
9.1INTRODUCTION105
TABLE 84BIOPROCESS CONTAINERS MARKET, BY REGION,
2017–2020 (USD MILLION)105
TABLE 85BIOPROCESS CONTAINERS MARKET, BY REGION,
2021–2026 (USD MILLION)105
9.2NORTH AMERICA106
FIGURE 20NORTH AMERICA: BIOPROCESS CONTAINERS MARKET SNAPSHOT107
TABLE 86NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION)108
TABLE 87NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)108
TABLE 88NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)108
TABLE 89NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)109
TABLE 90NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)109
TABLE 91NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)109
TABLE 92NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)110
TABLE 93NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)110
9.2.1US110
9.2.1.1The US dominates the North American bioprocess containers market110
TABLE 94US: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)111
TABLE 95US: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)111
TABLE 96US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)112
TABLE 97US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)112
TABLE 98US: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)112
TABLE 99US: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)113
9.2.2CANADA113
9.2.2.1Growing number of biopharmaceutical manufacturing facilities is supporting the growth of the market in Canada113
FIGURE 21CANADA: BIOLOGICS SALES, 2009-2018 (USD BILLION)113
TABLE 100CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)114
TABLE 101CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)114
TABLE 102CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)114
TABLE 103CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)115
TABLE 104CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)115
TABLE 105CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)115
9.3EUROPE116
TABLE 106EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION)116
TABLE 107EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)117
TABLE 108EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)117
TABLE 109EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)117
TABLE 110EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)118
TABLE 111EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)118
TABLE 112EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)118
TABLE 113EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)119
9.3.1GERMANY119
9.3.1.1Increasing adoption of single-use bioprocess systems by biopharmaceutical and CDMO companies to drive market growth119
TABLE 114GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)120
TABLE 115GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)120
TABLE 116GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)120
TABLE 117GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)121
TABLE 118GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)121
TABLE 119GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)121
9.3.2UK122
9.3.2.1Rising government support for biotechnology companies to propel the demand for advanced technologies in the UK122
TABLE 120UK: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)122
TABLE 121UK: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)123
TABLE 122UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)123
TABLE 123UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)123
TABLE 124UK: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)124
TABLE 125UK: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)124
9.3.3FRANCE124
9.3.3.1Increasing investments in life science R&D infrastructure development to support market growth124
TABLE 126FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)125
TABLE 127FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)125
TABLE 128FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)125
TABLE 129FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)126
TABLE 130FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)126
TABLE 131FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)126
9.3.4ITALY127
9.3.4.1High R&D investments in the field of biotechnology research to support market growth in Italy127
TABLE 132ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)127
TABLE 133ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)127
TABLE 134ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)128
TABLE 135ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)128
TABLE 136ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)128
TABLE 137ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)129
9.3.5ROE129
TABLE 138ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)129
TABLE 139ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)130
TABLE 140ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)130
TABLE 141ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)130
TABLE 142ROE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)131
TABLE 143ROE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)131
9.4ASIA PACIFIC131
FIGURE 22ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET SNAPSHOT132
TABLE 144ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION)133
TABLE 145ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION)133
TABLE 146ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)134
TABLE 147ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)134
TABLE 148ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)134
TABLE 149ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)135
TABLE 150ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)135
TABLE 151ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)135
9.4.1CHINA136
9.4.1.1China to witness the highest growth in the global bioprocess containers market136
TABLE 152CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)136
TABLE 153CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)137
TABLE 154CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)137
TABLE 155CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)137
TABLE 156CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)138
TABLE 157CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)138
9.4.2SOUTH KOREA138
9.4.2.1Government support to boost the production of biological to drive market growth138
TABLE 158SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)139
TABLE 159SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)139
TABLE 160SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)140
TABLE 161SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)140
TABLE 162SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)140
TABLE 163SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)141
9.4.3JAPAN141
9.4.3.1Expansion of biopharmaceutical manufacturing plants in Japan has created growth opportunities for BPC companies141
TABLE 164JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)142
TABLE 165JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)142
TABLE 166JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)142
TABLE 167JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)143
TABLE 168JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)143
TABLE 169JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)143
9.4.4INDIA144
9.4.4.1COVID-19 vaccines production has created significant demand for single-use bioprocess containers144
TABLE 170INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)145
TABLE 171INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)145
TABLE 172INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)145
TABLE 173INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)146
TABLE 174INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)146
TABLE 175INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)146
9.4.5ROAPAC147
TABLE 176ROAPAC: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)147
TABLE 177ROAPAC: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)148
TABLE 178ROAPAC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)148
TABLE 179ROAPAC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)148
TABLE 180ROAPAC: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)149
TABLE 181ROAPAC: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)149
9.5REST OF THE WORLD149
TABLE 182ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2017–2020 (USD MILLION)150
TABLE 183ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2021–2026 (USD MILLION)150
TABLE 184ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2017–2020 (USD MILLION)151
TABLE 185ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2021–2026 (USD MILLION)151
TABLE 186ROW: BIOPROCESS CONTAINERS MARKET, BY END USER,
2017–2020 (USD MILLION)151
TABLE 187ROW: BIOPROCESS CONTAINERS MARKET, BY END USER,
2021–2026 (USD MILLION)152
10COMPETITIVE LANDSCAPE153
10.1INTRODUCTION153
10.2RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS153
FIGURE 23BIOPROCESS CONTAINERS MARKET: RIGHT-TO-WIN STRATEGIES
ADOPTED BY KEY PLAYERS154
10.3MARKET SHARE ANALYSIS155
FIGURE 24BIOPROCESS CONTAINERS: MARKET SHARE ANALYSIS, 2020155
10.4COMPANY EVALUATION QUADRANT156
FIGURE 25BIOPROCESS CONTAINERS MARKET: COMPANY EVALUATION MATRIX, 2020156
10.4.1STARS156
10.4.2PERVASIVE PLAYERS156
10.4.3EMERGING LEADERS157
10.4.4PARTICIPANTS157
10.5COMPETITIVE SCENARIO157
10.5.1DEALS157
TABLE 188BIOPROCESS CONTAINERS MARKET: DEALS, JANUARY 2018-MAY 2021157
10.5.2OTHER DEVELOPMENTS159
11COMPANY PROFILES160
11.1KEY COMPANIES160
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1SARTORIUS STEDIM BIOTECH160
TABLE 189SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW160
FIGURE 26SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)161
TABLE 190SARTORIUS STEDIM BIOTECH: PRODUCT OFFERINGS161
TABLE 191SARTORIUS STEDIM BIOTECH: DEALS162
TABLE 192SARTORIUS STEDIM BIOTECH: OTHER DEVELOPMENTS162
11.1.2THERMO FISHER SCIENTIFIC INC.164
TABLE 193THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW164
FIGURE 27THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)165
TABLE 194THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS165
TABLE 195THERMO FISHER SCIENTIFIC INC.: DEALS166
TABLE 196THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS167
11.1.3DANAHER CORPORATION169
TABLE 197DANAHER CORPORATION: BUSINESS OVERVIEW169
FIGURE 28DANAHER CORPORATION: COMPANY SNAPSHOT (2020)170
TABLE 198DANAHER CORPORATION: PRODUCT OFFERINGS171
TABLE 199DANAHER CORPORATION: DEALS171
TABLE 200DANAHER CORPORATION: OTHER DEVELOPMENTS173
11.1.4MERCK KGAA175
TABLE 201MERCK KGAA: BUSINESS OVERVIEW175
FIGURE 29MERCK KGAA: COMPANY SNAPSHOT (2020)176
TABLE 202MERCK KGAA: PRODUCT OFFERINGS176
TABLE 203MERCK KGAA: OTHER DEVELOPMENTS177
11.1.5SAINT-GOBAIN178
TABLE 204SAINT-GOBAIN: BUSINESS OVERVIEW178
FIGURE 30SAINT-GOBAIN: COMPANY SNAPSHOT (2020)179
TABLE 205SAINT-GOBAIN: PRODUCT OFFERINGS179
TABLE 206SAINT-GOBAIN: DEALS180
TABLE 207SAINT-GOBAIN: OTHER DEVELOPMENTS181
11.1.6AVANTOR, INC.182
TABLE 208AVANTOR, INC.: BUSINESS OVERVIEW182
FIGURE 31AVANTOR, INC.: COMPANY SNAPSHOT (2020)183
TABLE 209AVANTOR, INC.: PRODUCT OFFERINGS183
TABLE 210AVANTOR, INC.: DEALS184
TABLE 211AVANTOR, INC.: OTHER DEVELOPMENTS184
11.1.7PARKER HANNIFIN CORPORATION185
TABLE 212PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW185
FIGURE 32PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2020)186
TABLE 213PARKER HANNIFIN: PRODUCT OFFERINGS186
TABLE 214PARKER HANNIFIN: OTHER DEVELOPMENTS187
11.1.8CORNING INCORPORATED188
TABLE 215CORNING INCORPORATED: BUSINESS OVERVIEW188
FIGURE 33CORNING INCORPORATED: COMPANY SNAPSHOT (2020)189
TABLE 216CORNING INCORPORATED: PRODUCT OFFERINGS190
11.1.9ENTEGRIS, INC.191
TABLE 217ENTEGRIS, INC.: BUSINESS OVERVIEW191
FIGURE 34ENTEGRIS, INC.: COMPANY SNAPSHOT (2020)192
TABLE 218ENTEGRIS, INC.: PRODUCT OFFERINGS192
TABLE 219ENTEGRIS, INC.: DEALS193
TABLE 220ENTEGRIS, INC.: OTHER DEVELOPMENTS193
11.1.10MEISSNER FILTRATION PRODUCTS, INC.194
TABLE 221MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW194
TABLE 222MEISSNER FILTRATION PRODUCTS, INC.: PRODUCT OFFERINGS194
11.1.11LONZA AG195
TABLE 223LONZA AG: BUSINESS OVERVIEW195
FIGURE 35LONZA AG: COMPANY SNAPSHOT (2020)196
TABLE 224LONZA AG: PRODUCT OFFERINGS196
11.1.12ANTYLIA SCIENTIFIC197
TABLE 225ANTYLIA SCIENTIFIC: BUSINESS OVERVIEW197
TABLE 226ANTYLIA SCIENTIFIC: PRODUCT OFFERINGS197
11.1.13FLEXBIOSYS INC.198
TABLE 227FLEXBIOSYS INC.: BUSINESS OVERVIEW198
TABLE 228FLEXBIOSYS INC.: PRODUCT OFFERINGS198
11.1.14MICHELIN GROUP199
TABLE 229MICHELIN GROUP: BUSINESS OVERVIEW199
TABLE 230MICHELIN GROUP: PRODUCT OFFERINGS199
TABLE 231MICHELIN GROUP: PRODUCT APPROVALS200
TABLE 232MICHELIN GROUP: DEALS200
11.1.15ABEC, INC.201
TABLE 233ABEC, INC.: BUSINESS OVERVIEW201
TABLE 234ABEC, INC.: PRODUCT OFFERINGS201
TABLE 235ABEC, INC.: DEALS202
TABLE 236ABEC, INC.: OTHER DEVELOPMENTS203
11.1.16CELLEXUS204
TABLE 237CELLEXUS: BUSINESS OVERVIEW204
TABLE 238CELLEXUS: PRODUCT OFFERINGS204
TABLE 239CELLEXUS: DEALS204
11.2OTHER COMPANIES205
11.2.1KEOFITT A/S205
TABLE 240KEOFITT A/S: COMPANY OVERVIEW205
11.2.2FUJIMORI KOGYO CO., LTD.205
TABLE 241FUJIMORI KOGYO CO., LTD.: COMPANY OVERVIEW205
11.2.3CESCO BIOENGINEERING CO., LTD.206
TABLE 242CESCO BIOENGINEERING CO., LTD.: COMPANY OVERVIEW206
11.2.4SOLIDA BIOTECH GMBH206
TABLE 243SOLIDA BIOTECH GMBH: COMPANY OVERVIEW206
11.2.5SATAKE CHEMICAL EQUIPMENT MFG., LTD.207
TABLE 244SATAKE CHEMICAL EQUIPMENT MFG., LTD.: COMPANY OVERVIEW207
11.2.6STOBBE PHARMA GMBH207
TABLE 245STOBBE PHARMA GMBH: COMPANY OVERVIEW207
11.2.7CELLTAINER BIOTECH BV208
TABLE 246CELLTAINER BIOTECH BV: COMPANY OVERVIEW208
11.2.8FOXX LIFE SCIENCES208
TABLE 247FOXX LIFE SCIENCES: COMPANY OVERVIEW208
11.2.9SHANGHAI LEPURE BIOTECH CO., LTD.209
TABLE 248SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW209
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX210
12.1DISCUSSION GUIDE210
12.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL212
12.3AVAILABLE CUSTOMIZATIONS214
12.4RELATED REPORTS215
12.5AUTHOR DETAILS216

お問合せフォーム